Literature DB >> 20484920

Deficiency in the serum-derived hyaluronan-associated protein-hyaluronan complex enhances airway hyperresponsiveness in a murine model of asthma.

Long Zhu1, Lisheng Zhuo, Koji Kimata, Etsuro Yamaguchi, Hideto Watanabe, Mark A Aronica, Vincent C Hascall, Kenji Baba.   

Abstract

BACKGROUND: Serum-derived hyaluronan (HA)-associated proteins (SHAPs), the heavy chains of inter-α-trypsin inhibitor, covalently bind to HA to form the SHAP-HA complex. The SHAP-HA complex is involved in the pathophysiology of inflammatory diseases, including rheumatoid arthritis. We investigated whether this complex is also involved in airway allergy.
METHODS: SHAP-HA-deficient (bikunin knockout, KO) mice and wild-type (WT) mice were immunized twice by intraperitoneal injection of ovalbumin (OVA) and exposed to aerosol OVA for 30 min each day for 2 weeks. Twenty-four hours after the final OVA challenge, airway responsiveness to inhaled methacholine (MCh) was measured, and analysis of bronchoalveolar lavage fluid (BALF) and lung histological studies were done.
RESULTS: Compared to WT mice, KO mice showed higher airway hyperresponsiveness to inhaled MCh and higher late-phase responses to OVA whereas the early-phase responses were similar. Cell differentials of BALF showed an increased number of macrophages and neutrophils in KO mice. Furthermore, decreased concentrations of soluble tumor necrosis factor receptor-1 (sTNFR1) were found in BALF from KO mice whereas the levels of Th1 and Th2 cytokines were not different from WT mice. Immunochemical study of the lung tissues revealed stronger staining of sTNFR1 in KO than in WT mice.
CONCLUSIONS: Our results suggest that in this murine asthma model, the SHAP-HA complex has an inhibitory role in the development of airway hyperresponsiveness and allergic airway inflammation which may be attributed, at least in part, to negative feedback mechanisms exerted by sTNFR1, the shedding of which from the cell surface might also be promoted by the SHAP-HA complex.
Copyright © 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20484920      PMCID: PMC2945275          DOI: 10.1159/000314362

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  52 in total

1.  TNF-alpha induces the late-phase airway hyperresponsiveness and airway inflammation through cytosolic phospholipase A(2) activation.

Authors:  Il-Whan Choi; Young-Suk Kim; Hyun-Mi Ko; Suhn-Young Im; Jae-Hong Kim; Hye-Jin You; Yong-Chul Lee; Jae-Hoon Lee; Young-Min Park; Hern-Ku Lee
Journal:  J Allergy Clin Immunol       Date:  2005-09       Impact factor: 10.793

2.  L-selectin and intercellular adhesion molecule 1 mediate lymphocyte migration to the inflamed airway/lung during an allergic inflammatory response in an animal model of asthma.

Authors:  E Keramidaris; T D Merson; D A Steeber; T F Tedder; M L Tang
Journal:  J Allergy Clin Immunol       Date:  2001-04       Impact factor: 10.793

3.  A serum-derived hyaluronan-associated protein (SHAP) is the heavy chain of the inter alpha-trypsin inhibitor.

Authors:  L Huang; M Yoneda; K Kimata
Journal:  J Biol Chem       Date:  1993-12-15       Impact factor: 5.157

4.  Distribution and elimination of intravenously injected urinary trypsin inhibitor.

Authors:  B M Jönsson-Berling; K Ohlsson
Journal:  Scand J Clin Lab Invest       Date:  1991-10       Impact factor: 1.713

Review 5.  Targeting TNF-alpha: a novel therapeutic approach for asthma.

Authors:  Christopher Brightling; Mike Berry; Yassine Amrani
Journal:  J Allergy Clin Immunol       Date:  2007-11-26       Impact factor: 10.793

6.  Pro- and anti-inflammatory factors cooperate to control hyaluronan synthesis in lung fibroblasts.

Authors:  Thomas S Wilkinson; Susan Potter-Perigo; Christina Tsoi; Leonard C Altman; Thomas N Wight
Journal:  Am J Respir Cell Mol Biol       Date:  2004-02-05       Impact factor: 6.914

7.  Mononuclear leukocytes bind to specific hyaluronan structures on colon mucosal smooth muscle cells treated with polyinosinic acid:polycytidylic acid: inter-alpha-trypsin inhibitor is crucial to structure and function.

Authors:  Carol A de la Motte; Vincent C Hascall; Judith Drazba; Sudip K Bandyopadhyay; Scott A Strong
Journal:  Am J Pathol       Date:  2003-07       Impact factor: 4.307

8.  Binding of haptoglobin, inter-alpha-trypsin inhibitor, and alpha 1 proteinase inhibitor to synovial fluid hyaluronate and the influence of these proteins on its degradation by oxygen derived free radicals.

Authors:  N Hutadilok; P Ghosh; P M Brooks
Journal:  Ann Rheum Dis       Date:  1988-05       Impact factor: 19.103

9.  The role of a soluble TNFalpha receptor fusion protein (etanercept) in corticosteroid refractory asthma: a double blind, randomised, placebo controlled trial.

Authors:  J B Morjaria; A J Chauhan; K S Babu; R Polosa; D E Davies; S T Holgate
Journal:  Thorax       Date:  2008-02-01       Impact factor: 9.139

10.  Unrestrained plethysmography is an unreliable measure of airway responsiveness in BALB/c and C57BL/6 mice.

Authors:  Andy Adler; Greg Cieslewicz; Charles G Irvin
Journal:  J Appl Physiol (1985)       Date:  2004-03-19
View more
  13 in total

1.  Hyaluronan expression as a significant prognostic factor in patients with malignant peripheral nerve sheath tumors.

Authors:  Kunihiro Ikuta; Hiroshi Urakawa; Eiji Kozawa; Eisuke Arai; Lisheng Zhuo; Naohisa Futamura; Shunsuke Hamada; Koji Kimata; Naoki Ishiguro; Yoshihiro Nishida
Journal:  Clin Exp Metastasis       Date:  2014-06-24       Impact factor: 5.150

Review 2.  The Inter-α-Trypsin Inhibitor Family: Versatile Molecules in Biology and Pathology.

Authors:  Megan S Lord; James Melrose; Anthony J Day; John M Whitelock
Journal:  J Histochem Cytochem       Date:  2020-07-08       Impact factor: 2.479

3.  Inhibition of hyaluronan synthesis alters sulfated glycosaminoglycans deposition during chondrogenic differentiation in ATDC5 cells.

Authors:  Yutaka Yoshioka; Eiji Kozawa; Hiroshi Urakawa; Eisuke Arai; Naohisa Futamura; Lisheng Zhuo; Koji Kimata; Naoki Ishiguro; Yoshihiro Nishida
Journal:  Histochem Cell Biol       Date:  2015-05-01       Impact factor: 4.304

Review 4.  Defining the versican interactome in lung health and disease.

Authors:  Fengying Tang; Jourdan E Brune; Mary Y Chang; Stephen R Reeves; William A Altemeier; Charles W Frevert
Journal:  Am J Physiol Cell Physiol       Date:  2022-06-01       Impact factor: 5.282

Review 5.  The role of hyaluronan in the pathobiology and treatment of respiratory disease.

Authors:  Stavros Garantziotis; Martin Brezina; Paolo Castelnuovo; Lorenzo Drago
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-01-08       Impact factor: 5.464

6.  Hyaluronan and layilin mediate loss of airway epithelial barrier function induced by cigarette smoke by decreasing E-cadherin.

Authors:  Rosanna Malbran Forteza; S Marina Casalino-Matsuda; Nieves S Falcon; Monica Valencia Gattas; Maria E Monzon
Journal:  J Biol Chem       Date:  2012-10-09       Impact factor: 5.157

7.  Hyaluronan synthesis inhibitor supplements the inhibitory effects of zoledronic acid on bone metastasis of lung cancer.

Authors:  Naohisa Futamura; Hiroshi Urakawa; Eisuke Arai; Eiji Kozawa; Naoki Ishiguro; Yoshihiro Nishida
Journal:  Clin Exp Metastasis       Date:  2013-01-04       Impact factor: 5.150

8.  Immobilized heavy chain-hyaluronic acid polarizes lipopolysaccharide-activated macrophages toward M2 phenotype.

Authors:  Hua He; Suzhen Zhang; Sean Tighe; Ji Son; Scheffer C G Tseng
Journal:  J Biol Chem       Date:  2013-07-22       Impact factor: 5.157

Review 9.  Implications for Extracellular Matrix Interactions With Human Lung Basal Stem Cells in Lung Development, Disease, and Airway Modeling.

Authors:  Shana M Busch; Zareeb Lorenzana; Amy L Ryan
Journal:  Front Pharmacol       Date:  2021-05-12       Impact factor: 5.810

10.  Inhibition of hyaluronan retention by 4-methylumbelliferone suppresses osteosarcoma cells in vitro and lung metastasis in vivo.

Authors:  E Arai; Y Nishida; J Wasa; H Urakawa; L Zhuo; K Kimata; E Kozawa; N Futamura; N Ishiguro
Journal:  Br J Cancer       Date:  2011-11-01       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.